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SUMMARY: The purpose of this study was to determine whether the ankle-brachial index (ABI) could be used to predict the
prognosis for a patient with intermittent claudication (IC).
We studied 611 patients prospectively during 28 months of follow-up. We analyzed the predictive power of using various levels
of ABI — 0.30 to 0.70 at 0.05 increments — in terms of the measure’s specificity (association with a favorable outcome after
exercise rehabilitation therapy) and sensitivity (association with a poor outcome after exercise rehabilitation therapy).  We found
that using an ABI of 0.30 as a cut-off value produced the lowest margin of error overall, but the predictive power was still low with
respect to identifying the patients with a poor prognosis after non-aggressive therapeutic treatment. Further study is needed to
perhaps identify a second factor that could increase the sensitivity of the test.
DESCRIPTORS:  Intermittent claudication.  Risk factors. Diagnostic. Atherosclerosis. Complications.
Intermittent claudication (IC) is an
early clinical manifestation of periph-
eral arterial occlusive disease (PAOD).
Its evolution is relatively mild, with
improvement in the majority of pa-
tients, permitting longer walking toler-
ance. Therefore, early clinical treat-
ment is important1 ,2 .
However, a significant number of
patients with IC do not improve with
noninvasive management or present a
worsening of their vascular condition
even with adequate management3 ,
leading to a poorer quality of life or
even to the risk of 1oosing the extrem-
ity.
Prior to clinical treatment it is de-
sirable to know which factors could
identify patients with a negative prog-
nosis. In this way patients could ben-
efit from early surgical or endovascular
treatment, enhancing the quality of life
and possibly changing the natural
course of the disease.
The ankle-brachial index (ABI)
permits an assessment of the level of
hemodynamic changes of the lower
limbs. Since the ankle blood pressure
varies with the systemic blood pres-
sure, we use this index to normalize the
values, by dividing the ankle systolic
blood pressure by the braquial systolic
blood pressure.
This value has been used as a pre-
dictive factor. A variety of values have
been suggested, but their validity has
been questioned3,4 .
The objective of this study was to
verify the value of the ABI, measured
when starting treatment, to predict the
prognosis of patients with intermittent
claudication submitted to clinica1 treat-
ment, with the 1owest margin of error.
PATIENTS  AND  METHODS
Five hundred and forty-three pa-
tients with IC of the lower limbs un-
dergoing clinical treatment for a me-
dian time of 28.9 months were pro-
spectively studied.
Upon admission, the ABI of all pa-
tients was recorded. Pressure in the up-
per limb was measured in the radial ar-
tery, and in both lower limbs in the dor-
salis pedis and posterior tibial arteries.
The highest value of systolic blood
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pressure of each leg (in dorsalis pedis
artery or in posterior tibial artery) was
divided by the highest value of the bra-
chial systolic blood pressure (right or
left arm).
The vascular outcome was de-
termined by measuring the maximum
walking distance using the progressive
treadmill test5 . Stabilization or increase
of the distance walked with a tolerance
of ± 30 meters was considered favor-
able (F).
The outcome of patients was coded
in relation to the values of ABI arbi-
trarily set between 0.30 and 0.70 in
0.05 increments.
The margin of error was calculated
for each ABI value established, taking
into account their corresponding levels
of sensitivity and specificity, using the
formula:
error1 + error2  (1)
where:
• error1= ”false negative” - proportion
of patients belonging to the category
”improvement”, whose ABI was lower
than the adopted value;
• error2 = “false positive” - proportion
of patients belonging to the category
”worsening”, whose ABI was higher
than the adopted value of ABI.
RESULTS
The results of the study are shown
in tables 1-3.
Table 1 shows the outcome of pa-
tients on distance walking according to
the iniital ABI values with various ar-
bitrary cutoff values.
Table 2 shows the sensitivity and
specificity levels for different values of
ABI. We found that with lower ABI
values, the sensitivity was higher and
the specificity was lower.
Table 3 presents the values result-
ing from applying the formula 1 to
each value of ABI. We observed that
the ABI cutoff value of 0.30 had the
smallest margins of error.
DISCUSSION
ABI is a simple measure permitting
the assessment of the rate of hemody-
namic change in the lower limbs by
comparing the pressures found in the
distal arteries of the leg with the sys-
temic pressure, normally measured in
the arm.
Most patients managed for IC im-
prove their walking tolerance; never-
theless, for a significant number (about
30%), their condition either stabilizes
or worsens. A poor prognosis has a
wide range of consequences, but as a
rule brings about a decreased quality of
life6 , in addition to leading to signifi-
cant socioeconomic problems.
The minimum time required for
achieving satisfactory results with ex-
ercise rehabilitation therapy is about
three to six months3,7 ,8 ,9 ,10 . In cases of
a poor prognosis, the opportunity for
a less invasive treatment may be lost
because of the occlusion of an arterial
stenosis2,11  or progression of the pre-
existing thrombosis. In these cases,
early surgical treatment may prove
more efficient12  and avoid later
revascularizations that will certainly be
more extensive.
Passage of time may also cause loss
of a surgical opportunity because of
deterioration of the clinical condition
and increase in the surgical risk13 ,14 .
The predictive factors could be
used to identify patients who would not
have a positive outcome with
noninvasive treatment and to alert phy-
sicians to the need for a surgical
therapy  (conventional or endovascular
surgery) at an early stage.
In the literature, the ABI has been
mentioned as a predictor of the vascu-
lar evolution and also of the clinical
progress in patients with IC; however,
its predictive power is controversial.
Table 1 – Evolution of patients
according to ABI.
Evolution
ABI Improvement worsening Total
Nº % Nº % Nº
<0.30 38 52 34 48 72
>0.30 357 75 114 25 471
<0.35 72 63 42 37 114
>0.35 323 75 106 25 429
<0.40 111 67 53 33 164
>0.40 284 75 95 25 379
<0.45 153 70 64 30 217
>0.45 242 74 84 26 326
<0.50 213 72 83 28 296
>0.50 182 74 65 26 247
<0.60 284 73 107 27 391
>0.60 111 73 41 27 152
<0.70 333 73 121 27 454
>0.70 62 69 27 31 89
ABI – Ankle-brachial Index: Ankle systolic
blood pressure of the affected limb divided by
brachial systolic blood pressure.
Table 2 – Levels of sensitivity and
specificity for different ABI values.
ABI Specificity Sensitivity
0.30 0.23 0.90
0.35 0.28 0.82
0.40 0.36 0.72
0.45 0.43 0.61
0.50 0.56 0.46
0.60 0.72 0.28
0.70 0.82 0.16
ABI – Ankle-brachial Index.
Table 3 – Margins of  error for the
different ABI .
ABI error1 error2 Error1+ error2
0.30 0.089 0.797 0.886
0.35 0.173 0.729 0.902
0.40 0.268 0.643 0.910
0.45 0.372 0.556 0.928
0.50 0.530 0.430 0.960
0.60 0.717 0.275 0.993
0.70 0.854 0.193 1.047
ABI – Ankle-brachial Index
Error 1 – False negative: Patients with
improvement with ABI below the cut-off value.
Error 2 – False positive: Patients with
worsening with ABI above the cut-off value.
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The validity of this indicator is ques-
tionable3,4, and with regard to the most
adequate cut-off value for ABI, uncer-
tainty exists concerning the value be-
low which exercise rehabilitation
therapy would likely be ineffec-
tive12,15 ,16 ,17 .
All works undertaken until now are
based upon the analysis of a pre-estab-
lished pressure indicator coupled to the
course of IC. In our study, we sought to
relate the progress of the IC in terms of
walking distance with different levels of
ABI, using the analysis of the sensitiv-
ity and specificity to find the best cut-
off value for ABI. The objective is to
find the ABI value that differentiates
between the cases whose course would
be favorable (sensitivity) and those of
poor prognosis (specificity). The best
ABI value would be the one with the
smallest margin of error for sensitivity
and specificity combined.
Low values of ABI, found at the
onset of treatment permit a high sen-
sitivity and a. very low specificity. The
converse was also observed (Table 2).
The predictive value of this indicator,
in such cases, becomes questionable.
We then observed that to consider a
change as significant, two measures of
ABI must vary by at lease 14%18 .  This
was not encountered in our study.
By assessing the margin of error
(formula 1), it was possible to under-
take the joint analysis described above,
matching the different results of the ar-
bitrarily established ABI values. We
observed that the ABI value with the
lowest margin of error was 0.30. How-
ever, although this value resulted in a
high sensitivity (90%), it also resulted
in a very low specificity (23%).
The inability to reliably and pro-
spectively identify patients who would
have a poor prognosis following exer-
cise rehabilitation therapy using ABI
scores of any level calls into question
the predictive value of ABI. Although
some researchers have reported a sig-
nificant correlation of ABI with the
course of vascular disease, they consid-
ered the practical value of the ABE as
a predictive test to be limited17,19  or ab-
sent3,4.
We conclude that the ABI value
with the smallest margin of error for
predicting the vascular progress of IC
of the lower limbs is 0.30. However,
because of its low specificity, its pre-
dictive power for identifying patients
who would not benefit from exercise
rehabilitation therapy is weak, render-
ing its use in isolation insufficient for
the outlining of the IC treatment pro-
tocol. Perhaps the association of ABI
to other variables will prove to be more
predictive.
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O objetivo deste estudo foi determi-
nar a evolução da distância de marcha
de pacientes com claudicação intermi-
tente relacionando com o índice torno-
zelo-braço (ITB) e o valor deste índi-
ce como fator preditivo para o prog-
nóstico desses pacientes.
Observou-se prospectivamente a
evolução de 611 pacientes durante 28
meses. Analisamos o valor preditivo do
ITB inicial usando vários valores de
corte — 0.30 a 0.70 em incrementos de
0.05 — em relação à especificidade
(associação com uma evolução favorá-
vel após tratamento clínico) e sensibi-
lidade (associação com uma evolução
desfavorável após tratamento clínico).
Encontramos o ITB de 0.30 como o
valor de corte produzindo a menor
margem de erro, mas seu valor
preditivo ainda foi baixo para identifi-
car os pacientes com mau prognóstico
para o tratamento não invasivo. Estu-
dos adicionais são necessários para se
identificar um fator adicional que pos-
sa aumentar a sensibilidade do teste.
DESCRITORES:  Fatores de risco.
Claudicação intermitente.   Diagnóstico.
Aterosclerose.  Complicações.
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